Buchumschlag

Adipocyte‐Targeted Nanotechnology and Cell‐Based Therapy for Obesity Treatment

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Yue Wu, Siqi Deng, Siyu Wei, Wenqi Wei, Yunxiang He, Junling Guo
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	ChemMedChem
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Adipocyte‐Targeted Nanotechnology and Cell‐Based Therapy for Obesity Treatment
von: Yue Wu, et al.
Veröffentlicht: (2025)

Targeting Tetraspanins at Cell Interfaces: Functional Modulation and Exosome‐Based Drug Delivery for Precise Disease Treatment
von: Kun Xu, et al.
Veröffentlicht: (2024)

Cuproptosis and Cuproptosis‐Based Synergistic Therapy for Cancer Treatment
von: Zhiyang Shen, et al.
Veröffentlicht: (2024)

Mitochondria‐Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes
von: Hao‐Ming Li, et al.
Veröffentlicht: (2024)

Polymer‐Based Nanoparticles for Inner Ear Targeted Trans Differentiation Gene Therapy
von: Thomas Foster, et al.
Veröffentlicht: (2024)

PROTAC‐Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies
von: Ambati Himaja, et al.
Veröffentlicht: (2025)

Pillar[n]arene‐Based Supramolecular Nanodrug Delivery Systems for Cancer Therapy
von: Shubin Wei, et al.
Veröffentlicht: (2025)

Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy
von: Yerim Jin, et al.
Veröffentlicht: (2024)

Targeting Tumor‐Associated Carbonic Anhydrases in Photothermal Therapy
von: Sébastien Clément, et al.
Veröffentlicht: (2025)

Front Cover: Polydopamine‐Based Light Responsive Nanoparticles with Magnetic Resonance Imaging Capabilities for Breast Cancer Photodynamic/Photothermal Therapy Combination Therapy (ChemMedChem 3/2026)
von: Yupeng Zhang, et al.
Veröffentlicht: (2026)

Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
von: A. Gerges, et al.
Veröffentlicht: (2024)

Tumor Microenvironment‐Responsive Multinucleated Nanocomplexes Loaded with Carbon Dots for Combined Photothermal/Chemodynamic Therapy of Breast Cancer
von: Zihan Zhu, et al.
Veröffentlicht: (2025)

Nuclear‐Targeted Boron‐Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma
von: Marcos Couto, et al.
Veröffentlicht: (2026)

Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape
von: Pengwen Chen, et al.
Veröffentlicht: (2024)

An Effective Reaction‐Based Virtual Screening Method to Discover New CDK8 Ligands
von: Wei Chen, et al.
Veröffentlicht: (2025)

Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
von: Chao Tang, et al.
Veröffentlicht: (2026)

Corrigendum: Nuclear‐Targeted Boron‐Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma
von: Marcos Couto, et al.
Veröffentlicht: (2026)

Bacterial Secondary Metabolites Embedded in Producer Cell Membranes and Antibiotics Targeting Their Biosynthesis
von: Zhao Xia, et al.
Veröffentlicht: (2024)

Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy
von: Lixiao Zhang, et al.
Veröffentlicht: (2025)

Advances in Lipid Nanoparticle‐Based Disease Treatment
von: Yujie Zhou, et al.
Veröffentlicht: (2025)

Silicon Phthalocyanines Functionalized with Axial Substituents Targeting PSMA: Synthesis and Preliminary Assessment of Their Potential for PhotoDynamic Therapy of Prostate Cancer
von: Martina Capozza, et al.
Veröffentlicht: (2024)

Development of a Neopentyl 211At‐Labeled Activated Ester Providing In Vivo Stable 211At‐Labeled Antibodies for Targeted Alpha Therapy
von: Masatoshi Tada, et al.
Veröffentlicht: (2024)

Russell Mechanism‐Mediated Cancer Therapy: A Minireview
von: Rufeng Zhang, et al.
Veröffentlicht: (2024)

Design, Synthesis, and Biological Evaluation of Indolin‐2‐One–Matrine Derivatives as Potential VEGFR‐2‐Targeting Agents for Hepatocellular Carcinoma
von: Ziyi Wang, et al.
Veröffentlicht: (2026)

Potent Antisickling Furaldehyde Analogs for Acute Sickle Cell Therapy: Enhanced Efficacy and Intravenous Formulation Potential
von: Abdelsattar M. Omar, et al.
Veröffentlicht: (2025)

One‐Step Assembly of Homogeneous DAR4 ADCs via a Traceless Fc Ligand‐Directed Acylation Strategy
von: Yue Zeng, et al.
Veröffentlicht: (2026)

Molecular Engineering of Cordycepin Derivatives for Enhanced Biological Activity and Stability
von: Yiming Gu, et al.
Veröffentlicht: (2025)

Recent Progress on Topical Drug Therapy for Corneal Neovascularization
von: Xin‐Can Huang, et al.
Veröffentlicht: (2025)

Self‐Assembling Peptide‐Based High‐Relaxivity Targeted MRI Contrast Agents
von: Andrew M. O'Brien, et al.
Veröffentlicht: (2024)

Design, Synthesis, and Biological Assessment of Novel Aminobenzidazole Agonists Targeting the Stimulator of Interferon Genes (STING) Receptor Signaling Pathway for Oncology Immunotherapy
von: Yiqing Fan, et al.
Veröffentlicht: (2025)

Programmable Intelligent DNA Nanoreactors (iDNRs) for in vivo Tumor Diagnosis and Therapy
von: Ying Shen, et al.
Veröffentlicht: (2024)

Progress of Mesoporous Silica Coated Gold Nanorods for Biological Imaging and Cancer Therapy
von: Jiaying Ma, et al.
Veröffentlicht: (2024)

Design, Synthesis, and Evaluation of Boron Dipyrromethene‐Based Fluorescent Probes Targeting BRAF for Melanoma Diagnosis
von: Mengqian Wang, et al.
Veröffentlicht: (2025)

Strategic Design and Development of Indole‐Based Compounds as Potent Malic Enzyme 3 Inhibitors for Pancreatic Tumor Therapy
von: Gaurav Sheth, et al.
Veröffentlicht: (2025)

Development of C646‐Based Proteolysis Targeting Chimeras Degraders of the Lysine Acetyltransferases CBP and p300
von: Francesco Fiorentino, et al.
Veröffentlicht: (2025)

Design and Synthesis of 68Ga‐Labeled Peptide‐Based Heterodimers for Dual Targeting of NTS1 and GRPR
von: Sacha Bodin, et al.
Veröffentlicht: (2025)

Structure‐Based Virtual Screening Identifies TREM2‐Targeted Small Molecules that Enhance Microglial Phagocytosis
von: Sungwoo Cho, et al.
Veröffentlicht: (2026)

Macrocyclic Inhibitors Targeting the Prime Site of the Fibrinolytic Serine Protease Plasmin
von: Simon J. A. Wiedemeyer, et al.
Veröffentlicht: (2024)

Nanomaterials‐Based Targeting of Long Non‐Coding RNAs in Cancer: A Cutting‐Edge Review of Current Trends
von: Fatemeh Davodabadi, et al.
Veröffentlicht: (2024)

Multitarget Anticancer Activity of Pyrazoline‐Based Hybrids: Insights into Apoptosis, Bovine Serum Albumin/DNA Interactions, and Caspase Targeting
von: Milena M. Petrović, et al.
Veröffentlicht: (2025)